The Procter & Gamble Company Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax
The Procter & Gamble Company (PG) reported Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax of -$156.00 million for the 12-month period ending 2013-06-30, per its 8-K filed 2013-10-28.
Discontinued › Notes › Derivative Instruments and Hedging Activities › Summary of Derivative Instruments › Effect of Net Investment Hedge on Results of Operations
us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax · last filed 2013-10-28
- The Procter & Gamble Company gain (loss) on derivative used in net investment hedge, after tax for fiscal 2011 was $1.18B.
- The Procter & Gamble Company gain (loss) on derivative used in net investment hedge, after tax for fiscal 2009 was $964.00M.
| Period end | Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax 12 month | Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax 12 month as first filed |
|---|---|---|
| 2013-06-30 | -$156.00M 8-K · filed 2013-10-28 | |
| 2012-06-30 | -$740.00M 8-K · filed 2013-10-28 | |
| 2011-06-30 | $1.18B 10-K · filed 2012-08-08 | -$1.18B 10-K · filed 2011-08-10 |
| 2010-06-30 | $789.00M 8-K · filed 2012-02-10 | |
| 2009-06-30 | $964.00M 10-K · filed 2010-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| Longevity Health Holdings, Inc. (XAGE) | United States | $0.006B | -0.09 |